Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis

(2012) Antonio-Javier Chamorro et al.   ADDICTION BIOLOGY

Prediction of Weight Loss and Regain Following Dietary, Lifestyle, and Pharmacologic Intervention

(2012) A Napolitano et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prevalence and Correlates of Eating Disorders in Adolescents

(2011) Sonja A. Swanson   ARCHIVES OF GENERAL PSYCHIATRY

Multiple-Dose Safety, Pharmacokinetics, and Pharmacodynamics of the μ-Opioid Receptor Inverse Agonist GSK1521498

(2011) Pradeep J. Nathan et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single-Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ-Opioid Receptor Inverse Agonist

(2011) Pradeep J. Nathan et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans

(2011) E A Rabiner et al.   MOLECULAR PSYCHIATRY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders

(2011) Martin Aigner et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity

(2010) J. G. Kang et al.   DIABETES OBESITY & METABOLISM

Compulsive overeating as an addiction disorder. A review of theory and evidence

(2009) Caroline Davis et al.   APPETITE

From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour

(2009) Pradeep J. Nathan et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Reward Processing by the Opioid System in the Brain

(2009) Julie Le Merrer et al.   PHYSIOLOGICAL REVIEWS

An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence

(2008) Raymond F. Anton et al.   ARCHIVES OF GENERAL PSYCHIATRY

Review Paper: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns

(2008) C. S. Elangbam   VETERINARY PATHOLOGY